slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 96,741
Current window 89,371-89,400
Pages 3,225
Rows per page 30
Component
89,371-89,400 of 96,741
06
Kering | Investor Presentation Deck | 63 slidesKering | Investor Presentation Deck | 63 slides · Kering
Conference presentation Investor relations Beat · Situation & Context1 hit
30
EP&L stands for Environmental Profit & Loss. The slide uses a bubble matrix to show impact distribution and a dual-line chart to show intensity reduction.Kering | Investor Presentation Deck | 63 slides · Kering
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
09
Includes a mechanism of action diagram, a market data table, and a comparison of current therapy limitations.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
22
Includes a table of prevalence/incidence for various indications and a diagram of the JAK-STAT signaling pathway.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
25
The table displays adverse events occurring in 2 or more patients. Data includes patient counts and percentages for both 'All' and 'Related' adverse events.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
30
The slide uses a split-layout: left side for clinical data results, right side for strategic positioning.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
32
Includes a waterfall plot of cell line dependency and a biological process diagram showing the MDM2-p53 feedback loop.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
39
The slide uses a split-layout to contrast technical mechanism/data (left) with strategic market opportunity (right).Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
01
Larimar Therapeutics | Investor Presentation Deck | 44 slidesLarimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations 1 hit
08
The slide uses a visual comparison of protein structures to explain the mechanism of action.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
20
Larimar Therapeutics | Investor Presentation Deck | 44 slidesLarimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
21
Larimar Therapeutics | Investor Presentation Deck | 44 slidesLarimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
40
Kaplan-Meier survival curve showing efficacy of FXN replacement therapy.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
11
Legend Biotech | Results Presentation Deck | 15 slidesLegend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Satisfaction1 hit
09
Includes quarterly revenue and operating profit trends, plus key strategic metrics.Lenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
05
The slide uses a comparative structure to highlight the margin difference between GCR (12-15%) and ODR (25-28%).Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Beat · Problem1 hit
09
The slide highlights the physical infrastructure and production capability.Lion Electric | Investor Presentation Deck | 30 slides · Lion Electric
Pitch deck Investor relations Beat · ProductLoop · Voice Of Customer1 hit
14
Includes a specific conditional order note at the bottom.Lion Electric | Investor Presentation Deck | 30 slides · Lion Electric
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
03
Lion Electric | Results Presentation Deck | 21 slidesLion Electric | Results Presentation Deck | 21 slides · Lion Electric
Conference presentation Investor relations 1 hit
09
Includes a conditional order for 50 Lion C from Highland Electrics.Lion Electric | Results Presentation Deck | 21 slides · Lion Electric
Conference presentation Investor relations 1 hit
07
The slide uses a timeline to show strategic milestones and pie charts to show revenue composition changes over time.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations 1 hit
10
LKQ | Results Presentation Deck | 62 slidesLKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations 1 hit
23
LKQ | Results Presentation Deck | 62 slidesLKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Solution1 hit
28
Includes a combo chart showing revenue, EBITDA, and EBITDA margin trend.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations 1 hit
37
LKQ | Results Presentation Deck | 62 slidesLKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
43
Includes a legend for blue dots indicating directors joined since 2018 and a footer note regarding age calculation date.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations 1 hit
44
LKQ | Results Presentation Deck | 62 slidesLKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations 1 hit
46
LKQ | Results Presentation Deck | 62 slidesLKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Loop · Mece Breakdown1 hit
10
The slide illustrates the interaction between THIO (telomere targeting) and standard checkpoint inhibitor therapies.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Solution1 hit
21
The plot highlights long-term benefit post-therapy and low mortality rates in the cohort.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit